首页> International journal of gynecological cancer : official journal of the International Gynecological Cancer Society> A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC).

A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC).

导出原文传递

翻译打印收藏纠错

第一作者： Agnieszka,Michael

第一单位： Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK A.Michael@surrey.ac.uk.

作者： Agnieszka,Michael ^[1] ; William,Wilson ^[2] ; Sunny,Sunshine ^[3] ; Nicola,Annels ^[3] ; Richard,Harrop ^[4] ; Daniel,Blount ^[5] ; Hardev,Pandha ^[3] ; Rosemary,Lord ^[6] ; Yen,Ngai ^[2] ; Shibani,Nicum ^[7] ; Laura,Stylianou ^[2] ; Stephen,Gwyther ^[8] ; Iain A,McNeish ^[9] ; Allan,Hackshaw ^[10] ; Jonathan,Ledermann ^[10]

作者单位： Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK A.Michael@surrey.ac.uk. ^[1] Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK. ^[2] Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK. ^[3] Oxular, Oxford, Oxfordshire, UK. ^[4] Barinthus Biotherapeutics (UK) Ltd, Oxford, Oxfordshire, UK. ^[5] Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK. ^[6] University College London, London, UK. ^[7] Surrey and Sussex NHS Healthcare Trust, Redhill, UK. ^[8] Department of Surgery and Cancer, Imperial College London, London, UK. ^[9] UCL Cancer Institute, University College London, UK. ^[10]

关键词 Carcinoma, Ovarian Epithelial